Excited to see our work on overcoming drug resistance in relapsed high-risk neuroblastoma out there! Huge collaboration with the good people at the Children's Cancer Institute and @sysbioire.bsky.social:
www.science.org/doi/10.1126/...
science.org
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma
Drug combinations using differential apoptotic components can overcome the impaired state of relapsed high-risk neuroblastoma.